These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21056489)

  • 1. Dosimetric predictor identification for radiation-induced liver disease after hypofractionated conformal radiotherapy for primary liver carcinoma patients with Child-Pugh Grade A cirrhosis.
    Liang SX; Huang XB; Zhu XD; Zhang WD; Cai L; Huang HZ; Li YF; Chen L; Liu MZ
    Radiother Oncol; 2011 Feb; 98(2):265-9. PubMed ID: 21056489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma.
    Xu ZY; Liang SX; Zhu J; Zhu XD; Zhao JD; Lu HJ; Yang YL; Chen L; Wang AY; Fu XL; Jiang GL
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):189-95. PubMed ID: 16542787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypofractionated three-dimensional conformal radiation therapy for primary liver carcinoma.
    Liang SX; Zhu XD; Lu HJ; Pan CY; Li FX; Huang QF; Wang AY; Chen L; Fu XL; Jiang GL
    Cancer; 2005 May; 103(10):2181-8. PubMed ID: 15812834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance.
    Liang SX; Zhu XD; Xu ZY; Zhu J; Zhao JD; Lu HJ; Yang YL; Chen L; Wang AY; Fu XL; Jiang GL
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):426-34. PubMed ID: 16690430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease.
    Cheng JC; Wu JK; Lee PC; Liu HS; Jian JJ; Lin YM; Sung JL; Jan GJ
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1502-9. PubMed ID: 15590181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic factor of primary liver cancer treated by hypofractionated three-dimensional conformal radiotherapy].
    Liang SX; Jiang GL; Zhu XD; Fu XL; Li FX; Huang QF; Wang AY; Chen L; Lu HJ
    Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):613-5. PubMed ID: 16438872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of radiation induced liver disease using artificial neural networks.
    Zhu J; Zhu XD; Liang SX; Xu ZY; Zhao JD; Huang QF; Wang AY; Chen L; Fu XL; Jiang GL
    Jpn J Clin Oncol; 2006 Dec; 36(12):783-8. PubMed ID: 17068085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication.
    Cheng JC; Wu JK; Huang CM; Liu HS; Huang DY; Cheng SH; Tsai SY; Jian JJ; Lin YM; Cheng TI; Horng CF; Huang AT
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):156-62. PubMed ID: 12182986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of 3-dimensional conformal hypofractionated single high-dose radiotherapy combined with transcatheter arterial chemoembolization for portal vein tumor thrombus in patients with hepatocellular carcinoma].
    Wu DH; Chen LH
    Ai Zheng; 2004 Jul; 23(7):825-8. PubMed ID: 15248921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
    Zhou ZH; Liu LM; Cheng WW; Meng ZQ; Lin JH; Chen Z; Zhang XJ; Jiang GL
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):222-6. PubMed ID: 16875612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inclusion of biological factors in parallel-architecture normal-tissue complication probability model for radiation-induced liver disease.
    Cheng JC; Liu HS; Wu JK; Chung HW; Jan GJ
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1150-6. PubMed ID: 15990021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy.
    Kim TH; Kim DY; Park JW; Kim SH; Choi JI; Kim HB; Lee WJ; Park SJ; Hong EK; Kim CM
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):225-31. PubMed ID: 17056199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies--mature results of the French Phase II RTF-1 trial.
    Mornex F; Girard N; Beziat C; Kubas A; Khodri M; Trepo C; Merle P
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1152-8. PubMed ID: 17145534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Magnetic resonance imaging findings of liver injury induced by three-dimensional conformal radiotherapy].
    Chen DC; Chen LH; Jin WD; Xu YK; Xu PJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Feb; 27(2):181-3, 187. PubMed ID: 17355931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.
    Claude L; Pérol D; Ginestet C; Falchero L; Arpin D; Vincent M; Martel I; Hominal S; Cordier JF; Carrie C
    Radiother Oncol; 2004 May; 71(2):175-81. PubMed ID: 15110451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for massive primary liver cancer].
    Sun HW; Chen LH; Wei CJ; Zheng XK; Li QS; Guan J
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jun; 29(6):1133-6. PubMed ID: 19726341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tolerance and efficacy of conformal radiotherapy for hepatocellular carcinoma in cirrhotic patients. Results of the French RTF1 phase II trial].
    Mornex F; Girard N; Merle P; Béziat C; Kubas A; Wautot V; Khodri M; Trepo C
    Cancer Radiother; 2005 Nov; 9(6-7):470-6. PubMed ID: 16219480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies.
    Ben-Josef E; Normolle D; Ensminger WD; Walker S; Tatro D; Ten Haken RK; Knol J; Dawson LA; Pan C; Lawrence TS
    J Clin Oncol; 2005 Dec; 23(34):8739-47. PubMed ID: 16314634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reappraisal of risk factors predicting liver complications from radiotherapy for hepatocellular carcinoma].
    Lee IJ; Seong J; Shim SJ; Han KH; Chon CY
    Korean J Hepatol; 2006 Sep; 12(3):420-8. PubMed ID: 16998294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.